Interv. cardiologist @ University Hospital Zurich | Coordinator of the angiography AGCRC CoreLaboratory | Bio-Eng. PhD in Computational Fluid Dynamics @ PoliTo
Zurich, Switzerland
Joined May 2010
- Tweets374
- Following67
- Followers427
- Likes885
Alessandro Candreva MD PhD retweeted
New insights from #PROSPECTII substudy of non-culprit lesions post #cvAMI found that both physiologically sig & even non-physiologically sig lesions demonstrated a moderate-to-high presence of high-risk plaque jacc.org/doi/10.1016/j.jcmg.…
@GreggWStone @Kketina #JACCIMG #cvImaging
Alessandro Candreva MD PhD retweeted
Top 🔟 Clinical Trials of 2024:
🔥 PREVENT
🔥 DanGer Shock
🔥 REDUCE-AMI
🔥 CLEAR SYNERGY (OASIS 9)
🔥 And more!
Read the details of the clinical trials here: bit.ly/41Kb7nn
Alessandro Candreva MD PhD retweeted
New @Nature
A mechanism for why durable weight loss is so difficult: epigenetic memory of fat cells
nature.com/articles/s41586-0…
@vonMeyenn @laurahinte
Alessandro Candreva MD PhD retweeted
"Is there a doctor on the plane?"✈️🩺
Responding to in-flight medical emergencies.
#MedTwitter
Alessandro Candreva MD PhD retweeted
Have we come a long way in treating acute myocardial infarction? Perusing the recommendations of the 1978 Harrison's Principles of Internal Medicine will leave you appalled! futurelearn.com/courses/arti… @FutureLearn
Alessandro Candreva MD PhD retweeted
Please 🙏🏻 repost @OSTOLab1 @ProfPaulEvans @PaneniLab @KralerSimon @BettinaHeideck1 @alecandreva @BarteltLab @MassiRuscica @society_eas @EAPCPresident @AboyansV @BNordestgaard @Metabolcenter
💥 Tenure-track Assistant Professorship on Pathophysiology of Cardio-metabolic disease @MedUniGraz to conduct cutting-edge translational cardiovascular 🧡 🧬 🔬 💊 research and implement sex and gender-specific novel factors lnkd.in/dxV7Wt8v
Alessandro Candreva MD PhD retweeted
New #JACCAsia state-of-the-art comprehensive review on updated clinical data of intravascular imaging–guided #PCI and #IVUS/OCT-derived stent optimization criteria in Asia. bit.ly/3MxQz8I #ACCIntl
Alessandro Candreva MD PhD retweeted
RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC
#ESCardio
ALT Panel A: The total number of events in the composite of first or recurrent hospitalization for heart failure or death from cardiovascular causes over a period of 24 months. Panel B: The total number of first or recurrent hospitalizations for heart failure over a period of 24 months. Panel C: The mean change from baseline over a period of 12 months in the score on the Kansas City Cardiomyopathy Questionnaire–Overall Summary (KCCQ-OS) for quality of life (scores range from 0 to 100, with higher scores indicating better health status).
Alessandro Candreva MD PhD retweeted
In MATTERHORN, among patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an assist device in the left ventricle at 1 year. Small trial, large noninferiority margin, less events than anticipated in the sample size assumption. #ESCCongress
nejm.org/doi/full/10.1056/NE…
Alessandro Candreva MD PhD retweeted
Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B.
This represent a paradigm shift in the diagnosis and treatment of these patients.
Alessandro Candreva MD PhD retweeted
Measurement & interpretation of hemodynamic data are integral aspects of treating patients w/ #HeartFailure.
Read the key points from a state-of-the-art review on practical guidance for hemodynamic assessment by RHC in the management of HF. 🔗 bit.ly/4cHMr0S #JACCHF
Alessandro Candreva MD PhD retweeted
Great study from @MatthEberhard @mergen_v @alecandreva @rengadr @rmanka_ and others from @RadiologieUSZ and @CardioZurich
@JACCJournals
⬇️⬇️⬇️⬇️⬇️⬇️
Seeing even more clearly through photon-counting CT (PCCT)? PCCT through in-plane resolution to 0.11mm and through plane resolution to 0.16mm improved coronary stenosis quantification using 3D-QCA as the reference standard. bit.ly/4awzMg5
#YesCCT #JACCIMG @MatthEberhard
Alessandro Candreva MD PhD retweeted
Congratulations to @BarbaraStahli from the @CardioZurich and @CTECresearch on winning the Georg Friedrich Götz Prize 🏆 for outstanding internationally recognized achievement! #MULTISTARS
@Unispital_USZ @UZH_en #FrankRuschitzka @FrancescoPaneni @ErsozluSara @ODzemali @PaneniLab
Alessandro Candreva MD PhD retweeted
Must-read review on the epidemiology and burden of heart failure in Asia in the latest issue of JACC: Asia. Highlights:
• In Asia, comprehensive data regarding the epidemiology and burden of HF remain limited.
• This review summarizes the occurrence, causes, outcomes, and management of HF in Asia, from both the GBD data and registry studies.
• HF remains a serious public health problem in Asia with significant regional variation; thus, strengthening the prevention and standardized management of HF in Asia is urgently needed.
jacc.org/doi/10.1016/j.jacas… @JACCJournals
Alessandro Candreva MD PhD retweeted
In-vivo virtual noncalcium with #photoncounting #yesCCT
-> Improved stenosis grading on noncalcium images
Fantastic collaboration with ccm.mc
shorturl.at/int07
@mergen_v @MatthEberhard
@rmanka_ @alecandreva @rengadr
@CardioZurich @RadiologieUSZ
Alessandro Candreva MD PhD retweeted
Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism ahajournals.org/doi/10.1161/…
Alessandro Candreva MD PhD retweeted
Coronary computed tomographic angiography (CCTA), often combined with FFRCT, is emerging as the primary tool for diagnosing coronary artery disease, assessing hemodynamic impact, and guiding revascularization planning. It effectively rules out atherosclerosis, monitors plaque progression, and evaluates non-obstructive ischemia. In cases of significant obstruction, CCTA aids in determining disease complexity and optimizes intervention strategies, including stent or graft placement. ow.ly/GLAv50Qv4nh
Alessandro Candreva MD PhD retweeted
February 22 and 23, 2024
What is it?
It is the appointment you don’t wanna miss if you’re interested in
💪🏻 challenging CHIPs
💥 calcium modification
📸 intracoronary imaging
Come join us in Lucerne if you want
🔥 debates
🔝discussions
🆒 workshops
luks.ch/veranstaltungen/lucc…
In our recent analysis, focal coronary lesions (identified by #PPG) presented not only adverse plaque composition, but also dangerous flow disturbance #WSS ! Focal lesions are the enemy!
thanks @CoreAalst @PoliTOnews @ColletCarlos
internationaljournalofcardio…
